We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
Trial record 8 of 2318 for:    melanoma

Clinical and Histological Features of Head and Neck Melanoma (head neck-mel)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02883933
Recruitment Status : Completed
First Posted : August 30, 2016
Last Update Posted : August 30, 2016
Information provided by (Responsible Party):

Study Description
Brief Summary:
The worldwide incidence of cutaneous melanoma has been increasing for the last 30 years in western populations. Among all melanomas, those located on the head and neck are more frequent than expected regarding the surface of this anatomical area, occur in older subjects than melanomas at other sites and have a worse prognosis than melanomas at other sites. The question whether head and neck melanomas could be a distinct entity has been debated.

Condition or disease Intervention/treatment
Melanoma Other: Data collection

Detailed Description:
Aim of the study was to compare clinical and histological characteristics between head and neck melanomas and melanomas at other sites.

Study Design

Study Type : Observational
Actual Enrollment : 1548 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Clinical and Histological Features of Head and Neck Melanoma
Study Start Date : January 2004
Primary Completion Date : December 2011
Study Completion Date : December 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Melanoma
U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
Patients with melanoma.
Other: Data collection

Outcome Measures

Primary Outcome Measures :
  1. Location of melanoma [ Time Frame: Day 0 ]
    Location of melanoma was classified in head and neck (scalp, forehead, temples, ears, neck, eyelids, nose, cheeks and area around mouse/chin) or other location (upper limb, lower limb, trunk, hand and foot).

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with melanoma.

Inclusion Criteria:

  • patients with melanoma
  • melanoma diagnosed between January 2004 and December 2011
  • patients living in Champagne-Ardenne
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02883933

Chu de Reims
Reims, France, 51092
Sponsors and Collaborators
CHU de Reims
More Information

Responsible Party: CHU de Reims
ClinicalTrials.gov Identifier: NCT02883933     History of Changes
Other Study ID Numbers: 2015Ao006
First Posted: August 30, 2016    Key Record Dates
Last Update Posted: August 30, 2016
Last Verified: August 2016

Additional relevant MeSH terms:
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms, Nerve Tissue
Nevi and Melanomas